Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

139 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Berger JS, et al. Among authors: avanzini f. JAMA. 2006 Jan 18;295(3):306-13. doi: 10.1001/jama.295.3.306. JAMA. 2006. PMID: 16418466
Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012.
Baviera M, Avanzini F, Marzona I, Tettamanti M, Vannini T, Cortesi L, Fortino I, Bortolotti A, Merlino L, Trevisan R, Roncaglioni MC. Baviera M, et al. Among authors: avanzini f. Nutr Metab Cardiovasc Dis. 2017 Jan;27(1):54-62. doi: 10.1016/j.numecd.2016.10.006. Epub 2016 Oct 24. Nutr Metab Cardiovasc Dis. 2017. PMID: 27956023
Trends and determinants of calcium antagonist usage after acute myocardial infarction (the GISSI experience).
Zuanetti G, Latini R, Avanzini F, Franzosi MG, Maggioni AP, Colombo F, Nicolis E, Mauri F. Zuanetti G, et al. Among authors: avanzini f. Am J Cardiol. 1996 Jul 15;78(2):153-7. doi: 10.1016/s0002-9149(96)90388-4. Am J Cardiol. 1996. PMID: 8712135
High pulse pressure and low mean arterial pressure: two predictors of death after a myocardial infarction.
Avanzini F, Alli C, Boccanelli A, Chieffo C, Franzosi MG, Geraci E, Maggioni AP, Marfisi RM, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; GISSI-Prevenzione investigators. Avanzini F, et al. J Hypertens. 2006 Dec;24(12):2377-85. doi: 10.1097/ J Hypertens. 2006. PMID: 17082719
Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.
Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A; PPP Collaborative Group. Sacco M, et al. Among authors: avanzini f. Diabetes Care. 2003 Dec;26(12):3264-72. doi: 10.2337/diacare.26.12.3264. Diabetes Care. 2003. PMID: 14633812 Clinical Trial.
Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: analysis of the GISSI-3 database.
Avanzini F, Ferrario G, Santoro L, Peci P, Giani P, Santoro E, Franzosi MG, Tognoni G; Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico-3 Investigators. Avanzini F, et al. Am Heart J. 2002 Dec;144(6):1018-25. doi: 10.1067/mhj.2002.126739. Am Heart J. 2002. PMID: 12486426 Clinical Trial.
Overall cardiovascular risk still ignored in general practice care of hypertension.
Camisasca P, Avanzini F, Alli C, Colombo F, Tognoni G; Studio sul Trattamento Antipertensivo nella Pratica ambulatoriale (STAP) participants. Camisasca P, et al. Among authors: avanzini f. J Cardiovasc Risk. 2002 Jun;9(3):147-52. doi: 10.1177/174182670200900303. J Cardiovasc Risk. 2002. PMID: 12202837
Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study.
Marzona I, Avanzini F, Lucisano G, Tettamanti M, Baviera M, Nicolucci A, Roncaglioni MC; Risk & Prevention Collaborative Group. Marzona I, et al. Among authors: avanzini f. Acta Diabetol. 2017 Feb;54(2):123-131. doi: 10.1007/s00592-016-0899-0. Epub 2016 Oct 7. Acta Diabetol. 2017. PMID: 27718051
Use of beta-blocking agents in secondary prevention after myocardial infarction: a case for evidence-based medicine? GISSI experience, 1984-1993. The Gruppo Italiano di Studio sulla Sopravvivenza nell'Infarto Miocardico (GISSI) Investigators.
Avanzini F, Zuanetti G, Latini R, Colombo F, Santoro E, Maggioni AP, Franzosi MG, Tognoni G. Avanzini F, et al. Eur Heart J. 1997 Sep;18(9):1447-56. doi: 10.1093/oxfordjournals.eurheartj.a015471. Eur Heart J. 1997. PMID: 9458451
Appropriate use of antiplatelets: is prescription in daily practice influenced by the global cardiovascular risk?
Monesi L, Avanzini F, Barlera S, Caimi V, Lauri D, Longoni P, Roccatagliata D, Tombesi M, Tognoni G, Roncaglioni MC. Monesi L, et al. Among authors: avanzini f. Eur J Clin Pharmacol. 2005 Sep;61(8):595-601. doi: 10.1007/s00228-005-0948-z. Epub 2005 Jul 15. Eur J Clin Pharmacol. 2005. PMID: 16021439
139 results
Jump to page